Capital Square
LLY icon

Capital Square’s Eli Lilly LLY Stock Holding History

Capital Square’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.04M Sell
4,353
-367
-8% -$433K 2.22% 4
2026
Q2 		$5.61M Sell
4,720
-60
-1% -$61.3K 2.47% 3
2026
Q1 		$4.23M Sell
4,780
-772
-14% -$783K 1.95% 7
2025
Q4 		$5.97M Sell
5,552
-68
-1% -$65K 3.04% 3
2025
Q3 		$4.29M Sell
5,620
-77
-1% -$57.3K 2.19% 5
2025
Q2 		$4.52M Buy
5,697
+508
+10% +$395K 2.41% 4
2025
Q1 		$4.29M Buy
5,189
+115
+2% +$95.7K 2.52% 3
2024
Q4 		$3.99M Buy
5,074
+14
+0.3% +$11.6K 2.26% 4
2024
Q3 		$4.48M Sell
5,060
-192
-4% -$173K 2.72% 3
2024
Q2 		$4.55M Buy
5,252
+326
+7% +$261K 2.96% 3
2024
Q1 		$3.83M Buy
4,926
+131
+3% +$93.2K 2.71% 3
2023
Q4 		$2.8M Buy
4,795
+408
+9% +$238K 3.16% 4
2023
Q3 		$2.66M Sell
4,387
-4
-0.1% -$2.06K 3.59% 3
2023
Q2 		$2.06M Sell
4,391
-48
-1% -$20.1K 1.91% 12
2023
Q1 		$1.64M Sell
4,439
-35
-0.8% -$11.8K 1.51% 17
2022
Q4 		$1.64M Sell
4,474
-33
-0.7% -$11.7K 1.48% 18
2022
Q3 		$1.46M Buy
4,507
+225
+5% +$71.3K 1.32% 21
2022
Q2 		$1.39M Sell
4,282
-9
-0.2% -$2.7K 1.15% 23
2022
Q1 		$1.23M Sell
4,291
-8
-0.2% -$2.06K 0.88% 37
2021
Q4 		$1.12M Buy
4,299
+8
+0.2% +$2.03K 0.77% 41
2021
Q3 		$985K Buy
4,291
+3
+0.1% +$740 0.7% 46
2021
Q2 		$1.02M Sell
4,288
-2
-0% -$402 0.75% 44
2021
Q1 		$791K Buy
4,290
+27
+0.6% +$5.28K 0.59% 57
2020
Q4 		$719K Buy
4,263
+18
+0.4% +$2.69K 0.6% 56
2020
Q3 		$628K Buy
4,245
+67
+2% +$10.4K 0.65% 52
2020
Q2 		$686K Sell
4,178
-217
-5% -$33.3K 0.73% 41
2020
Q1 		$610K Sell
4,395
-213
-5% -$29.3K 0.71% 38
2019
Q4 		$605K Buy
+4,608
New +$534K 0.58% 50

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

Capital Square's LLY Position: Q3 2026 in Review

Capital Square reduced its Eli Lilly (LLY) stake by 7.8% in Q3 2026, selling an estimated $433K and leaving 4,353 shares worth $5.04M. The position accounts for 2.22% of the portfolio, ranked #4.

Capital Square first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $5.97M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capital Square held 4,353 shares of Eli Lilly worth $5.04M as of Q3 2026.
  • Capital Square sold 367 Eli Lilly shares in Q3 2026, an estimated $433K.
  • Eli Lilly made up 2.22% of Capital Square's portfolio in Q3 2026, its #4 holding.
  • Capital Square first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • Capital Square's Eli Lilly position peaked at $5.97M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital Square's 13F filing for Q3 2026, filed 19 Oct 2026.